Literature DB >> 1483640

Issues in mandatory economic assessment of pharmaceuticals.

B S Bloom1.   

Abstract

Mesh：

Year:  1992        PMID： 1483640     DOI： 10.1377/hlthaff.11.4.197

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN： 0278-2715            Impact factor:   6.301


× No keyword cloud information.
  3 in total

1.  Timing and timeliness in medical care evaluation.

Authors:  B S Bloom; A M Fendrick
Journal:  Pharmacoeconomics       Date:  1996-03       Impact factor: 4.981

2.  The emerging government requirement for economic evaluation of pharmaceuticals.

Authors:  M Drummond
Journal:  Pharmacoeconomics       Date:  1994       Impact factor: 4.981

Review 3.  The need for an iterative process for assessing economic outcomes associated with SSRIs.

Authors:  T L Skaer; D A Sclar; L M Robison; R S Galin
Journal:  Pharmacoeconomics       Date:  2000-09       Impact factor: 4.981
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.